Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE: Acarbose in Patients with CHD and IGT
NCT00829660Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Feb 2009
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of acarbose in coronary heart disease (CHD), impaired glucose tolerance (IGT), sponsored by University of Oxford. Started Feb 2009; status: completed.
02
Drugs
acarbose
03
Conditions
coronary heart disease (CHD)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00829660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00829660.